Journal profile · Multiple
HIV Research & Clinical Practice
ISSN 2578-7489 · eISSN 2578-7470 · TAYLOR & FRANCIS LTD · ENGLAND
HIV Research & Clinical Practice: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.04; fully open access; APC charged, amount not published; median 79 days to acceptance (64 articles, last 24 months); acceptance rate 43% (journal website); 29 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
HIV Research & Clinical Practice is published by TAYLOR & FRANCIS LTD and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are HIV/AIDS Research and Interventions, HIV-related health complications and treatments and HIV/AIDS drug development and treatment, together about 57.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
*Please note that HIV Research & Clinical Practice converted to a full Open Access journal from Volume 22 (2022) and archive content will be made free to access. Please note, from 2022 the Print ISSN is not in active use as this journal is no longer published in print. HIV Research and Clinical Practice is devoted to presenting information on the latest developments in clinical and translational research related to HIV, as well as advances in science and care that directly affect clinical practice. This journal enables readers to obtain the most up-to-date, innovative research from around the world. In an era of increasingly well tolerated antiretroviral therapy (ART) much focus of research in the HIV field is examining the complex interplay of inflammation, ageing, and the development of chronic comorbidities in people with HIV. HIV Research and Clinical Practice aims to provide an authoritative forum for this area, with a focus on impactful clinical and translational research, as well as advances in clinical care. This international, peer-reviewed journal also intends to publish research undertaken with strong implementation science principles , whether supporting testing and treatment for HIV, best practices in prevention, or acute or chronic aspects of HIV care. The overarching principle is to improve quality of care, and quality of life, for all people with HIV, as well as those at risk of HIV acquisition also. As access to successful HIV treatment and care improves globally, an increasing emphasis on quality of life and long-term outcomes can emerge. Aspects of holistic care based in HIV may improve, strengthen, and support healthcare systems and enable better provision of care for all. HIV has much to teach us about the contributions of a chronic pro-inflammatory infection to frailty, cancer, and renal, bone, neurocognitive, cardiovascular disease, amongst others. As biomarkers and targets for interventions are established in the context of HIV, so we hope there may be benefits for all those who age, with or without the added burden of HIV. As we understand more about healthcare systems and how heightened surveillance of people with HIV must lead to improved quality and length of life, so we hope this knowledge may also have benefits for all. HIV Research and Clinical Practice welcomes authors and researchers to submit their work on: Therapeutic clinical trials, diagnostic clinical trials, or preventative clinical trials; including reports of clinic
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Tristan BarberPublisher website
Editorial board by country: none in mainland China; most named United States 7, United Kingdom 3, Nigeria 2, Germany 1, Spain 1 (15 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- HIV/AIDS Research and InterventionsMedicine26.7%
- HIV-related health complications and treatmentsMedicine18.1%
- HIV/AIDS drug development and treatmentMedicine12.8%
- HIV Research and TreatmentImmunology and Microbiology10.7%
- HIV, Drug Use, Sexual RiskMedicine4.4%
- Adolescent Sexual and Reproductive HealthHealth Professions4%
- Pneumocystis jirovecii pneumonia detection and treatmentMedicine3.3%
- Ethics in Clinical ResearchMedicine2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: Elsevier BIOBASE, ISI Alerting Services
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.04LetPub ·
- Impact factor (publisher) 2025
- 2.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.9Publisher website ·
- CiteScore 2026-06
- 2.2LetPub ·
- CiteScore (publisher) 2025
- 2.2Publisher website ·
- SJR 2026-06
- 0.58LetPub ·
- SJR (publisher) 2025
- 0.58Publisher website ·
- SNIP 2026-06
- 0.6LetPub ·
- SNIP (publisher) 2025
- 0.6Publisher website ·
- h-index
- 16OpenAlex ·
- i10-index
- 38OpenAlex ·
- 2-year mean citedness
- 1.94OpenAlex ·
- Self-citation rate
- 4.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 29LetPub ·
- Downloads per year (publisher)
- 117,000Publisher website ·
Articles by year OpenAlex count · 183 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 31 | 31 | 7 |
| 2025 | 29 | 29 | 49 |
| 2024 | 41 | 41 | 140 |
| 2023 | 15 | 15 | 104 |
| 2022 | 13 | 13 | 94 |
| 2021 | 18 | 14 | 234 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
79 daysMedian, submission to acceptance · P25–P75 59 days – 113 days
- Acceptance to online
- median 10 days (64 articles)
- Submission to online
- median 101 days
- Sample
- 64 articles with submission and acceptance dates (67 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Acceptance rate (publisher)
- 43%Publisher website ·
- Submission to first decision
- 28 daysPublisher website ·
- First decision after review
- 36 daysPublisher website ·
- Acceptance to publication 2025
- 8 daysPublisher website ·
- Submission to publication 2025
- 28 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted11
- brief reportsHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
- case reportsHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
- commentsHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
- data notesHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
- editorialsHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
- letters to the editorHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
- meeting reportsHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
- methodsHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
- patient perspectivesHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
- research articlesHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
- reviewsHIV Research & Clinical Practice accepts Research Articles, Reviews, Patient Perspectives, Brief Reports, Case Reports, Meeting Reports, Comments, Methods, Data…Length not stated
Policy excerpts from the journal's websiteAuthorship, Open access
- Authorship
UNAIDS terminology guidelines adoption Model summary
The journal adopts the UNAIDS terminology guidelines, all authors need to ensure their submission uses the preferred terminology as described in the following: https://www.unaids.org/sites/default/files/media_asset/2015_terminology_guidelines_en.pdf
Source ↗Publisher website ·- Open access Open access
Open access journal Model summary
HIV Research & Clinical Practice is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reach new readers, not j…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- TAYLOR & FRANCIS LTD
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 2578-7489
- Electronic ISSN
- 2578-7470
- Latest issue on the website
- Volume 27, Issue 1 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about HIV Research & Clinical Practice
What CAS zone is HIV Research & Clinical Practice in?
In the 2025 upgraded edition of the CAS Journal Ranking, HIV Research & Clinical Practice is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of HIV Research & Clinical Practice?
The latest impact factor listed by LetPub is 2.04; CiteScore 2.2, h-index 16.
How long does peer review take at HIV Research & Clinical Practice?
Based on the dates recorded on 64 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 79 days (interquartile range 59–113 days); authors report an average review time of about 14 weeks; the journal's website gives an acceptance rate of 43%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of HIV Research & Clinical Practice based?
Of the 15 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (7), United Kingdom (3) and Nigeria (2). Counted from the institutions listed on the board page; for reference only.
Which databases index HIV Research & Clinical Practice?
According to LetPub and DOAJ records, HIV Research & Clinical Practice is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is HIV Research & Clinical Practice open access, and what is the APC?
HIV Research & Clinical Practice is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .